These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15120686)

  • 21. Age at diagnosis of deaf babies: a retrospective analysis highlighting the advantage of newborn hearing screening.
    Canale A; Favero E; Lacilla M; Recchia E; Schindler A; Roggero N; Albera R
    Int J Pediatr Otorhinolaryngol; 2006 Jul; 70(7):1283-9. PubMed ID: 16488484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Duchenne muscular dystrophy: systematic neonatal screening and earlier detection of carriers.
    Plauchu H; Dellamonica C; Cotte J; Robert JM
    J Genet Hum; 1980 Dec; 28(4):65-82. PubMed ID: 7205199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving recognition of Duchenne muscular dystrophy: a retrospective case note review.
    van Ruiten HJ; Straub V; Bushby K; Guglieri M
    Arch Dis Child; 2014 Dec; 99(12):1074-7. PubMed ID: 25187493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Orthopedic outcomes of long-term daily corticosteroid treatment in Duchenne muscular dystrophy.
    King WM; Ruttencutter R; Nagaraja HN; Matkovic V; Landoll J; Hoyle C; Mendell JR; Kissel JT
    Neurology; 2007 May; 68(19):1607-13. PubMed ID: 17485648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cystic fibrosis diagnosed after 2 months of age leads to worse outcomes and requires more therapy.
    Sims EJ; Clark A; McCormick J; Mehta G; Connett G; Mehta A;
    Pediatrics; 2007 Jan; 119(1):19-28. PubMed ID: 17200267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delayed diagnosis of Duchenne muscular dystrophy.
    Mohamed K; Appleton R; Nicolaides P
    Eur J Paediatr Neurol; 2000; 4(5):219-23. PubMed ID: 11030068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Follow-Up for Duchenne Muscular Dystrophy Newborn Screening: A Proposal.
    Kwon JM; Abdel-Hamid HZ; Al-Zaidy SA; Mendell JR; Kennedy A; Kinnett K; Cwik VA; Street N; Bolen J; Day JW; Connolly AM
    Muscle Nerve; 2016 Aug; 54(2):186-91. PubMed ID: 27170260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Delayed diagnosis of Duchenne muscular dystrophy in Chile].
    de los Angeles Avaria M; Kleinsteuber K; Herrera L; Carvallo P
    Rev Med Chil; 1999 Jan; 127(1):65-70. PubMed ID: 10436681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short developmental milestone risk assessment tool to identify Duchenne muscular dystrophy in primary care.
    van Dommelen P; van Dijk O; de Wilde JA; Verkerk PH
    Orphanet J Rare Dis; 2024 May; 19(1):192. PubMed ID: 38730494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adherence to american academy of pediatrics recommendations for cardiac care among female carriers of duchenne and becker muscular dystrophy.
    Bobo JK; Kenneson A; Kolor K; Brown MA
    Pediatrics; 2009 Mar; 123(3):e471-5. PubMed ID: 19254982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating families' satisfaction with early hearing detection and intervention services in Massachusetts.
    MacNeil JR; Liu CL; Stone S; Farrell J
    Am J Audiol; 2007 Jun; 16(1):29-56. PubMed ID: 17562754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Newborn screening for Duchenne muscular dystrophy: a psychosocial study.
    Parsons EP; Clarke AJ; Hood K; Lycett E; Bradley DM
    Arch Dis Child Fetal Neonatal Ed; 2002 Mar; 86(2):F91-5. PubMed ID: 11882550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is it the right time for an infant screening for Duchenne muscular dystrophy?
    Vita GL; Vita G
    Neurol Sci; 2020 Jul; 41(7):1677-1683. PubMed ID: 32112218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delayed diagnosis in duchenne muscular dystrophy: data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet).
    Ciafaloni E; Fox DJ; Pandya S; Westfield CP; Puzhankara S; Romitti PA; Mathews KD; Miller TM; Matthews DJ; Miller LA; Cunniff C; Druschel CM; Moxley RT
    J Pediatr; 2009 Sep; 155(3):380-5. PubMed ID: 19394035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The survival advantage of patients with cystic fibrosis diagnosed through neonatal screening: evidence from the United States Cystic Fibrosis Foundation registry data.
    Lai HJ; Cheng Y; Farrell PM
    J Pediatr; 2005 Sep; 147(3 Suppl):S57-63. PubMed ID: 16202784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review of outcomes of neonatal screening for cystic fibrosis versus non-screening in Europe.
    Dankert-Roelse JE; Mérelle ME
    J Pediatr; 2005 Sep; 147(3 Suppl):S15-20. PubMed ID: 16202775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deflazacort in Duchenne muscular dystrophy: a comparison of two different protocols.
    Biggar WD; Politano L; Harris VA; Passamano L; Vajsar J; Alman B; Palladino A; Comi LI; Nigro G
    Neuromuscul Disord; 2004 Sep; 14(8-9):476-82. PubMed ID: 15336688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From hearing screening to cochlear implantation: cochlear implants in children under 3 years of age.
    Profant M; Kabátová Z; Simková L
    Acta Otolaryngol; 2008 Apr; 128(4):369-72. PubMed ID: 18368567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Newborn Screening for the Diagnosis and Treatment of Duchenne Muscular Dystrophy.
    Farrar MA; Kariyawasam D; Grattan S; Bayley K; Davis M; Holland S; Waddel LB; Jones K; Lorentzos M; Ravine A; Wotton T; Wiley V;
    J Neuromuscul Dis; 2023; 10(1):15-28. PubMed ID: 36373292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Early Care (0-3 Years) In Duchenne Muscular Dystrophy Meeting Report.
    Armstrong N; Apkon S; Berggren KN; Braun C; Ciafaloni E; Connolly A; Kennedy A; Kuntz N; Mathews K; McGuire M; Parad R; Scavina M; Scharf RJ; Waldrop M
    J Neuromuscul Dis; 2024; 11(2):525-533. PubMed ID: 38189762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.